Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 22 | 2025 | 1081 | 2.830 |
Why?
|
| Heart Failure | 23 | 2025 | 2393 | 2.260 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2025 | 158 | 1.120 |
Why?
|
| Vascular Resistance | 4 | 2025 | 196 | 0.890 |
Why?
|
| Hypertension, Pulmonary | 5 | 2023 | 460 | 0.830 |
Why?
|
| Cardiac Rehabilitation | 1 | 2023 | 29 | 0.790 |
Why?
|
| Renal Dialysis | 4 | 2025 | 948 | 0.770 |
Why?
|
| Self Care | 1 | 2023 | 226 | 0.720 |
Why?
|
| Myocarditis | 1 | 2022 | 133 | 0.690 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 377 | 0.600 |
Why?
|
| Patient Care Team | 1 | 2023 | 571 | 0.600 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 244 | 0.590 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 11 | 0.580 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 5 | 0.580 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2018 | 45 | 0.570 |
Why?
|
| Stroke Volume | 3 | 2025 | 541 | 0.560 |
Why?
|
| Heart, Artificial | 1 | 2018 | 69 | 0.550 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2022 | 302 | 0.540 |
Why?
|
| Heart Transplantation | 4 | 2024 | 877 | 0.530 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 489 | 0.500 |
Why?
|
| Drug Overdose | 1 | 2017 | 74 | 0.490 |
Why?
|
| Pulmonary Artery | 4 | 2024 | 457 | 0.480 |
Why?
|
| Metoprolol | 2 | 2025 | 21 | 0.480 |
Why?
|
| Shock, Cardiogenic | 3 | 2025 | 178 | 0.420 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 167 | 0.390 |
Why?
|
| Kidney Failure, Chronic | 3 | 2025 | 951 | 0.350 |
Why?
|
| Electrocardiography | 1 | 2017 | 1014 | 0.350 |
Why?
|
| Humans | 42 | 2025 | 132061 | 0.340 |
Why?
|
| Acute Kidney Injury | 3 | 2025 | 672 | 0.320 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2023 | 762 | 0.320 |
Why?
|
| Ventricular Function, Left | 3 | 2024 | 551 | 0.290 |
Why?
|
| Treatment Outcome | 14 | 2025 | 13028 | 0.280 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2025 | 655 | 0.250 |
Why?
|
| Thrombosis | 2 | 2022 | 524 | 0.250 |
Why?
|
| Homocysteine | 1 | 2005 | 119 | 0.230 |
Why?
|
| Prosthesis Implantation | 2 | 2024 | 156 | 0.230 |
Why?
|
| Middle Aged | 18 | 2025 | 28964 | 0.210 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 215 | 0.200 |
Why?
|
| Health Status | 1 | 2025 | 402 | 0.200 |
Why?
|
| Retrospective Studies | 17 | 2024 | 17419 | 0.200 |
Why?
|
| Cancer Care Facilities | 1 | 2022 | 36 | 0.200 |
Why?
|
| Quality of Life | 5 | 2025 | 2137 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 185 | 0.190 |
Why?
|
| Renal Replacement Therapy | 2 | 2021 | 158 | 0.190 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2022 | 44 | 0.180 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2023 | 107 | 0.180 |
Why?
|
| Hypothermia | 1 | 2021 | 66 | 0.180 |
Why?
|
| Hyponatremia | 1 | 2022 | 74 | 0.170 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2020 | 19 | 0.170 |
Why?
|
| Hypothermia, Induced | 1 | 2021 | 170 | 0.160 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 97 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2023 | 343 | 0.160 |
Why?
|
| Rivaroxaban | 1 | 2020 | 57 | 0.160 |
Why?
|
| Male | 18 | 2025 | 64922 | 0.160 |
Why?
|
| Plasmapheresis | 1 | 2019 | 33 | 0.160 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 66 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2020 | 74 | 0.150 |
Why?
|
| Palliative Care | 1 | 2023 | 457 | 0.150 |
Why?
|
| Exercise Tolerance | 2 | 2025 | 90 | 0.150 |
Why?
|
| Pyridones | 1 | 2020 | 134 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2023 | 800 | 0.150 |
Why?
|
| Time Factors | 5 | 2024 | 6448 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 256 | 0.140 |
Why?
|
| Heparin | 1 | 2019 | 212 | 0.140 |
Why?
|
| Cardiology | 1 | 2023 | 498 | 0.140 |
Why?
|
| Aged | 11 | 2025 | 21406 | 0.140 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 332 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 233 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 429 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2020 | 333 | 0.130 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2022 | 461 | 0.130 |
Why?
|
| Adult | 10 | 2025 | 31568 | 0.130 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2019 | 137 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 622 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 495 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 152 | 0.130 |
Why?
|
| Risk Factors | 6 | 2024 | 10941 | 0.130 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 97 | 0.130 |
Why?
|
| Mortality | 1 | 2018 | 268 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 853 | 0.120 |
Why?
|
| Female | 17 | 2025 | 70712 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 3091 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2025 | 1659 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 518 | 0.120 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 88 | 0.110 |
Why?
|
| Patient Selection | 1 | 2018 | 737 | 0.110 |
Why?
|
| Prognosis | 3 | 2021 | 5009 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 305 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2018 | 855 | 0.110 |
Why?
|
| Exercise Test | 1 | 2015 | 259 | 0.110 |
Why?
|
| Abscess | 1 | 2015 | 142 | 0.110 |
Why?
|
| Drainage | 1 | 2015 | 264 | 0.100 |
Why?
|
| Acute Disease | 1 | 2017 | 1160 | 0.100 |
Why?
|
| Radiology | 1 | 2015 | 127 | 0.100 |
Why?
|
| Hospitalization | 2 | 2019 | 1898 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 36 | 0.100 |
Why?
|
| Respiratory System Agents | 1 | 2023 | 3 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 5409 | 0.100 |
Why?
|
| Endoscopy | 1 | 2015 | 289 | 0.100 |
Why?
|
| Walk Test | 1 | 2023 | 29 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2023 | 127 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 2092 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 222 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 224 | 0.090 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2012 | 41 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2023 | 88 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 461 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1057 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1176 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 156 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1866 | 0.080 |
Why?
|
| Young Adult | 3 | 2020 | 9957 | 0.080 |
Why?
|
| Incidence | 4 | 2019 | 3380 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2020 | 3142 | 0.080 |
Why?
|
| Heart | 1 | 2013 | 700 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1301 | 0.070 |
Why?
|
| Survival Rate | 3 | 2019 | 2192 | 0.070 |
Why?
|
| Equipment Design | 2 | 2021 | 615 | 0.070 |
Why?
|
| Echocardiography | 2 | 2025 | 1129 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 758 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 918 | 0.060 |
Why?
|
| Anticoagulants | 2 | 2022 | 609 | 0.060 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2025 | 14 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2017 | 6567 | 0.060 |
Why?
|
| Vitamin B 12 | 1 | 2005 | 62 | 0.060 |
Why?
|
| United States | 5 | 2019 | 11658 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 435 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 1572 | 0.050 |
Why?
|
| Folic Acid | 1 | 2005 | 288 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 78 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 309 | 0.050 |
Why?
|
| Coma | 1 | 2021 | 57 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7102 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 204 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 50 | 0.040 |
Why?
|
| Prealbumin | 1 | 2020 | 29 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 56 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 181 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1353 | 0.040 |
Why?
|
| Neprilysin | 1 | 2019 | 21 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 238 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 1227 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2020 | 93 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 351 | 0.040 |
Why?
|
| Warfarin | 1 | 2020 | 129 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 178 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 293 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1573 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 187 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2018 | 137 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 307 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 668 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1247 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 561 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1686 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1131 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3736 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1234 | 0.030 |
Why?
|
| Medicare | 1 | 2018 | 448 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1163 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2697 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 791 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 1728 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 570 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 38 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 59 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 1085 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 20562 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3406 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 819 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3350 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3834 | 0.020 |
Why?
|
| Child | 1 | 2022 | 25789 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 34882 | 0.010 |
Why?
|